# Ultragenyx Pharmaceutical Inc.: Acquisition or disposition completed (Form 8-K, 2026-11-03)

**Trigger Strength Score:** 75/100

| Field | Value |
|---|---|
| Company | Ultragenyx Pharmaceutical Inc. |
| Ticker | RARE |
| CIK | 1515673 |
| Filed | 2026-11-03 |
| Event date | 2026-10-30 |
| Primary trigger | Acquisition or disposition completed |
| All items | 2.01 Acquisition or disposition completed; 2.02 Results of operations; 2.05 Exit or restructuring costs |
| Location | Novato, CA |
| SIC code | 2834 |
| Accession | 0001193125-26-445342 |

## Why this score
- Primary trigger: Acquisition or disposition completed.
- Several material items in one filing.
- Filed in the last 3 days.

Source: SEC EDGAR Form 8-K current reports (https://www.sec.gov/Archives/edgar/data/1515673/000119312526445342/rare-20261030.htm). Last refreshed: 2026-11-04T09:16:40.251Z.
Event classification uses the item numbers companies report on Form 8-K; read the filing itself before acting. Informational only; not investment advice and not an offer or solicitation to buy or sell any security.